The Regulation and Immune Signature of Retrotransposons in Cancer

<p dir="ltr">Advances in sequencing technologies and the bioinformatic analysis of big data facilitate the study of jumping genes’ activity in the human genome in cancer from a broad perspective. Retrotransposons, which move from one genomic site to another by a copy-and-paste mechan...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Maisa I. Alkailani (15070764) (author)
مؤلفون آخرون: Derrick Gibbings (17019075) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513560020779008
author Maisa I. Alkailani (15070764)
author2 Derrick Gibbings (17019075)
author2_role author
author_facet Maisa I. Alkailani (15070764)
Derrick Gibbings (17019075)
author_role author
dc.creator.none.fl_str_mv Maisa I. Alkailani (15070764)
Derrick Gibbings (17019075)
dc.date.none.fl_str_mv 2023-08-30T00:00:00Z
dc.identifier.none.fl_str_mv 10.3390/cancers15174340
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/The_Regulation_and_Immune_Signature_of_Retrotransposons_in_Cancer/24174204
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Oncology and carcinogenesis
transposable elements
mobile genome
insertions
tumorigenesis
immunity
type I IFN
jumping genes
dc.title.none.fl_str_mv The Regulation and Immune Signature of Retrotransposons in Cancer
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Advances in sequencing technologies and the bioinformatic analysis of big data facilitate the study of jumping genes’ activity in the human genome in cancer from a broad perspective. Retrotransposons, which move from one genomic site to another by a copy-and-paste mechanism, are regulated by various molecular pathways that may be disrupted during tumorigenesis. Active retrotransposons can stimulate type I IFN responses. Although accumulated evidence suggests that retrotransposons can induce inflammation, the research investigating the exact mechanism of triggering these responses is ongoing. Understanding these mechanisms could improve the therapeutic management of cancer through the use of retrotransposon-induced inflammation as a tool to instigate immune responses to tumors.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancers<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/cancers15174340" target="_blank">https://dx.doi.org/10.3390/cancers15174340</a></p>
eu_rights_str_mv openAccess
id Manara2_13483eacd871f52eacedea354a47fa8a
identifier_str_mv 10.3390/cancers15174340
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/24174204
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling The Regulation and Immune Signature of Retrotransposons in CancerMaisa I. Alkailani (15070764)Derrick Gibbings (17019075)Biomedical and clinical sciencesOncology and carcinogenesistransposable elementsmobile genomeinsertionstumorigenesisimmunitytype I IFNjumping genes<p dir="ltr">Advances in sequencing technologies and the bioinformatic analysis of big data facilitate the study of jumping genes’ activity in the human genome in cancer from a broad perspective. Retrotransposons, which move from one genomic site to another by a copy-and-paste mechanism, are regulated by various molecular pathways that may be disrupted during tumorigenesis. Active retrotransposons can stimulate type I IFN responses. Although accumulated evidence suggests that retrotransposons can induce inflammation, the research investigating the exact mechanism of triggering these responses is ongoing. Understanding these mechanisms could improve the therapeutic management of cancer through the use of retrotransposon-induced inflammation as a tool to instigate immune responses to tumors.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancers<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/cancers15174340" target="_blank">https://dx.doi.org/10.3390/cancers15174340</a></p>2023-08-30T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/cancers15174340https://figshare.com/articles/journal_contribution/The_Regulation_and_Immune_Signature_of_Retrotransposons_in_Cancer/24174204CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/241742042023-08-30T00:00:00Z
spellingShingle The Regulation and Immune Signature of Retrotransposons in Cancer
Maisa I. Alkailani (15070764)
Biomedical and clinical sciences
Oncology and carcinogenesis
transposable elements
mobile genome
insertions
tumorigenesis
immunity
type I IFN
jumping genes
status_str publishedVersion
title The Regulation and Immune Signature of Retrotransposons in Cancer
title_full The Regulation and Immune Signature of Retrotransposons in Cancer
title_fullStr The Regulation and Immune Signature of Retrotransposons in Cancer
title_full_unstemmed The Regulation and Immune Signature of Retrotransposons in Cancer
title_short The Regulation and Immune Signature of Retrotransposons in Cancer
title_sort The Regulation and Immune Signature of Retrotransposons in Cancer
topic Biomedical and clinical sciences
Oncology and carcinogenesis
transposable elements
mobile genome
insertions
tumorigenesis
immunity
type I IFN
jumping genes